A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden

Authors

  • Oscar Laurin Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden
  • Simona Baculea Global Market Access and Health Policy, Janssen Global Services LLC, High Wycombe, UK
  • Sarah Côté Global Market Access and Health Policy, Janssen Global Services LLC, Toronto, Canada
  • Samuel Spigelman Global Medical Affairs, Janssen Research and Development LLC, Raritan, NJ, USA
  • Robert Szulkin SDS Life Science, Stockholm, Sweden
  • Kelvin HM Kwok Schain Research AB, Stockholm, Sweden
  • Frida Schain Schain Research AB, Stockholm, Sweden
  • Christina V. Jones Schain Research AB, Stockholm, Sweden
  • Markus Aly Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden

DOI:

https://doi.org/10.2340/sju.v59.40016

Keywords:

Bladder-intact event-free survival, chemoradiation, chemotherapy, cystectomy, radiotherapy, muscle-invasive bladder cancer, overall survival, Sweden

Abstract

N/A

Downloads

Download data is not yet available.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660

Voskuilen CS, van de Kamp MW, Schuring N, Mertens LS, Noordzij A, Pos F, et al. Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: a convenient alternative to 5-fluorouracil. Radiother Oncol. 2020 Sep 1;150:275–80. https://doi.org/10.1016/j.radonc.2020.07.057 DOI: https://doi.org/10.1016/j.radonc.2020.07.057

Kimura T, Ishikawa H, Kojima T, Kandori S, Kawahara T, Sekino Y, et al. Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future. Jpn J Clin Oncol. 2020 Sep 28;50(10):1097–107. https://doi.org/10.1093/jjco/hyaa155 DOI: https://doi.org/10.1093/jjco/hyaa155

de Ruiter BM, van de Kamp MW, van Steenbergen JPZ, Franckena M, Boormans JL, de Feijter JM, et al. A multicenter retrospective cohort series of muscle-invasive bladder cancer patients treated with definitive concurrent chemoradiotherapy in daily practice. Eur Urol Open Sci. 2022 May 1;39:7–13. https://doi.org/10.1016/j.euros.2022.02.010 DOI: https://doi.org/10.1016/j.euros.2022.02.010

Ding H, Fan N, Ning Z, Ma D. Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: a meta-analysis. Front Oncol. 2020 Oct 14;10:564779. https://doi.org/10.3389/fonc.2020.564779 DOI: https://doi.org/10.3389/fonc.2020.564779

Schemper M, Kaider A, Wakounig S, Heinze G. Estimating the correlation of bivariate failure times under censoring. Stat Med. 2013 Nov 30;32(27):4781–90. https://doi.org/10.1002/sim.5874 DOI: https://doi.org/10.1002/sim.5874

Westergren DO, Gårdmark T, Lindhagen L, Chau A, Malmström PU. A nationwide, population based analysis of patients with organ confined, muscle invasive bladder cancer not receiving curative intent therapy in Sweden from 1997 to 2014. J Urol. 2019 Nov;202(5):905–12. https://doi.org/10.1097/JU.0000000000000350 DOI: https://doi.org/10.1097/JU.0000000000000350

Bamias A, Tsantoulis P, Zilli T, Papatsoris A, Caparrotti F, Kyratsas C, et al. Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospective analysis. Cancer Med. 2016 Mar 22;5(6):1098–107. https://doi.org/10.1002/cam4.685 DOI: https://doi.org/10.1002/cam4.685

Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register – a sample survey for year 1998. Acta Oncol. 2009 Jan 1;48(1):27–33. https://doi.org/10.1080/02841860802247664 DOI: https://doi.org/10.1080/02841860802247664

Brooke HL, Talbäck M, Hörnblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–73. https://doi.org/10.1007/s10654-017-0316-1 DOI: https://doi.org/10.1007/s10654-017-0316-1

Downloads

Additional Files

Published

2024-09-02

How to Cite

Laurin, O., Baculea, S., Côté, S., Spigelman, S., Szulkin, R., Kwok, K. H., … Aly, M. (2024). A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden. Scandinavian Journal of Urology, 59, 137–140. https://doi.org/10.2340/sju.v59.40016

Issue

Vol. 59 (2024)

Section

Research letter

License

Copyright (c) 2024 Oscar Laurin, Simona Baculea, Sarah Côté, Samuel Spigelman, Robert Szulkin, Kelvin HM Kwok, Frida Schain, Christina V. Jones, Markus Aly

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work. 

Crossref
Scopus
Google Scholar
Europe PMC

Funding data